You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仟源醫藥(300254.SZ):截至目前公司8個通過一致性評價的產品進入國家藥品集採目錄
格隆匯 08-09 07:13

格隆匯8月9日丨仟源醫藥(300254.SZ)近期在接待機構投資者調研時表示,截至目前公司8個通過一致性評價的產品進入國家藥品集採目錄,其中蒙脱石散、鹽酸坦索羅辛緩釋膠囊、鹽酸氟西汀膠囊、鹽酸氨溴索分散片、阿哌沙班片中標國家藥品集採,而鹽酸西那卡塞片、利伐沙班片、依巴斯汀片未中標國家藥品集採;其他藥品未進入國家藥品集採目錄。國家藥品集採對公司業績產生了一定的影響,公司將積極探索新的銷售模式,拓展家庭藥師品牌的影響力並提升網上商城的運營效率,努力開拓OTC市場;同時公司將整合內部資源,努力降本增效,以減緩這部分壓力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account